Stein R S, Flexner J M
South Med J. 1984 Dec;77(12):1599-601. doi: 10.1097/00007611-198412000-00034.
Three patients were treated empirically with anti-platelet agents, prednisone, plasmapheresis, and prostacyclin for the classical clinical syndrome of thrombotic thrombocytopenic purpura (TTP). All three patients initially responded, then relapsed after one to 13 months with a clinical picture characteristic of immunogenic thrombocytopenic purpura (ITP). At relapse, all three had thrombocytopenia without microangiopathy or other causes of thrombocytopenia. All responded to splenectomy. This complication of TTP may become more common with improved survival in TTP. Recognition may prevent inappropriate therapy.
三名患有血栓性血小板减少性紫癜(TTP)典型临床综合征的患者接受了经验性抗血小板药物、泼尼松、血浆置换和前列环素治疗。所有三名患者最初均有反应,但在1至13个月后复发,临床表现为免疫性血小板减少性紫癜(ITP)。复发时,所有三名患者均有血小板减少,无微血管病或其他血小板减少原因。所有患者对脾切除术均有反应。随着TTP生存率的提高,TTP的这种并发症可能会变得更加常见。认识到这一点可避免不适当的治疗。